Detection of carbamazepine-induced changes in valproic acid relative clearance in man by simple pharmacokinetic screening

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 8, 1997, Pages 751-756

  Yukawa, Eiji ^a   Honda, Tomoo ^a   Ohdo, Shigehiro ^a   Higuchi, Shun ^a   Aoyama, Toshinobu ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPUTER PROGRAM; DRUG CLEARANCE; EPILEPSY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MODEL; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE;

EID: 0030883580     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06106.x     Document Type: Article

References (15)

1. Beal, S. L., Sheiner, L. B. (1992) NONMEM Users' Guides. NONMEM Project Group, University of California at San Francisco
2. Bourgeois, B. F. D. (1988) Pharmacologic interactions between valproate and other drugs. Am. J. Med. 84 (Suppl. 1A): 29-33
3. Bowdle, T. A., Indravandan, H. P., Levy, R. H., Wilensky, A. J. (1980) Valproic acid dosage and plasma protein binding and clearance. Clin. Pharmacol. Ther. 28: 486-492
4. Chiba, K., Suganuma, T., Ishizaki, T., Iriki, T., Shirai, Y., Naitoh, H., Hori, M. (1985) Comparison of steady-state pharmacokinetics of valproic acid in children between monotherapy and multiple antiepileptic drug treatment. J. Pediatr. 106: 653-658
5. Cloyd, J. C., Fischer, J. H., Kriel, R. L., Kraus, D. M. (1993) Valproic acid pharmacokinetics in children. VI. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin. Pharmacol. Ther. 53: 22-29
6. Gram, L., Flachs, H., Wurtz-Jorgensen, A., Parnas, J., Anderson, B. (1979) Sodium valproate, serum level and clinical effect in epilepsy: a controlled study. Epilepsia 20: 303-312
7. Hall, K., Otten, N., Johnston, B., Irvine-Meek, J., Leroux, M., Seshia, S. (1985) A multivariable analysis of factors governing the steady-state pharmacokinetics of valproic acid in 52 young epileptics. J. Clin. Pharmacol. 25: 261-268
8. May, T., Rambeck, B. (1985) Serum concentrations of valproic acid: influence of dose and comedication. Ther. Drug Monit. 7: 387-390
9. Rylance, G. W., Moreland, T. A., Cowan, M. D., Clark, D. C. (1982) Liver volume estimation using ultrasound scanning. Arch. Dis. Child. 57: 283-286
10. Schobben, F., Van Der Kleijn, E., Gabreels, F. J. M. (1975) Pharmacokinetics of di-n-propylacetate in epileptic patients. Eur. J. Clin. Pharmacol. 8: 97-105
11. Sheiner, L. B., Benet, L. Z. (1985) Premarketing observational studies of population pharmacokinetics of new drugs. Clin. Pharmacol. Ther. 38: 481-487
12. Vajda, F. J. E., Drummer, O. H., Morris, P. M., McNeil, J. J., Bladin, P. F. (1978) Gas chromatographic measurement of plasma levels of sodium valproate: tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics. Clin. Exp. Pharmacol. Physiol. 5: 67-73
13. Yukawa, E. (1995a) Population-based investigation of carbamazepine relative clearance using routine clinical pharmacokineticc data in Japan: a multiple peak approach feasibility study for pharmacokinetic screening. Clin. Drug Invest. 10: 29-39
14. Yukawa, E. (1995b) A feasibility study of the multiple-peak approach for pharmacokinetic screening: population-based investigation of valproic acid relative clearance using routine clinical pharmacokinetic data. J. Pharm. Pharmacol. 47: 1053-1057
15. Yukawa, E., Suzuki, A., Higuchi, S., Aoyama, T. (1991) Influence of age and concurrent medication on steady-state valproic acid serum level-dose ratios in Japanese paediatric patients. J. Clin. Pharmacol. Ther. 16: 291-297